Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 58, 2023 - Issue 8
Submit an article Journal homepage
154
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Development and validation of a nomogram to predict recompensation in HBV-related cirrhosis with ascites as the single first decompensating event

Shifei WenDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Jiajia RuanDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Jiaming ShenDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Xia WangDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Guangde YangDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Juanjuan FuDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
,
Li LiDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaView further author information
&
Xiucheng PanDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9706-9458View further author information
ORCID Icon show all
Pages 915-922 | Received 09 Dec 2022, Accepted 12 Feb 2023, Published online: 23 Feb 2023

References

  • Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–1761.
  • Ju YC, Jun DW, Choi J, et al. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis. World J Gastroenterol. 2018;24(40):4606–4614.
  • D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–231.
  • Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2019;27:846–865.
  • Pose E, Torrents A, Reverter E, et al. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement. J Hepatol. 2021;75(2):275–283.
  • Kim TH, Um SH, Lee YS, et al. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Aliment Pharmacol Ther. 2022;55(1):83–96.
  • Xu X, Wang H, Zhao W, et al. Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study. BMJ Open. 2021;11(6):e043083.
  • European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460.
  • Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151(4):356–363.
  • de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974.
  • Wang Q, Zhao H, Deng Y, et al. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. J Hepatol. 2022;77(6):1564–1572.
  • Planas R, Montoliu S, Balleste B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4(11):1385–1394.
  • World Health Organization. Guidelines for the prevention, care, and treatment of persons with chronic hepatitis B infection: 2015 March. Geneva: World Health Organization; 2015.
  • Chang ML, Cheng JS, Chien RN, et al. Hepatitis flares are associated with better outcomes than no flare in patients with decompensated cirrhosis and chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2020;18(9):2064.e2–2072.e2.
  • Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391(10138):2417–2429.
  • Aravinthan AD, Barbas AS, Doyle AC, et al. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. Transpl Int. 2017;30(11):1140–1149.
  • Garcia-Martinez R, Caraceni P, Bernardi M, et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58(5):1836–1846.
  • Alukal JJ, John S, Thuluvath PJ. Hyponatremia in cirrhosis: an update. Am J Gastroenterol. 2020;115(11):1775–1785.
  • Porcel A, Díaz F, Rendón P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162(3):323–328.
  • Wu SL, Zheng YX, Tian ZW, et al. Scoring systems for prediction of mortality in decompensated liver cirrhosis: a meta-analysis of test accuracy. World J Clin Cases. 2018;6(15):995–1006.
  • Dezső K, Nagy P, Paku S. Human liver regeneration following massive hepatic necrosis: two distinct patterns. J Gastroenterol Hepatol. 2020;35(1):124–134.
  • Jang JW, Choi JY, Kim YS, et al. Effects of virologic response to treatment on short- and long-term outcomes of patients with chronic hepatitis B virus infection and decompensated cirrhosis. Clin Gastroenterol Hepatol. 2018;16(12):1954–1963 e3.
  • Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381(9865):468–475.
  • Liu K, Choi J, Le A, et al. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis. Aliment Pharmacol Ther. 2019;50(9):1037–1048.
  • Zhang QQ, An X, Liu YH, et al. Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis. Virol J. 2011;8:72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.